Two recent fatalities linked to plasma donations at Grifols collection centres in Winnipeg have raised urgent concerns regarding the safety of paid plasma donation programmes. The cases have prompted Health Canada to investigate and have led local officials to consider potential regulatory changes.
A Life Cut Short
Rodiyat Alabede, a promising 22-year-old student at the University of Winnipeg, moved to Canada from Nigeria nearly four years ago, eager to pursue a career in social work. Known for her warmth and compassion, she dedicated herself to supporting vulnerable members of her West African community. Tragically, her aspirations were cut short when Ms. Alabede collapsed during a plasma donation on 25 October. Her family friend, Ifeoluwa Oyewumi, recalled receiving a heart-wrenching call as her emergency contact. Rushing to St. Boniface Hospital, he arrived only to discover that she had passed away.
“All the doctors could tell us is that her heart stopped beating during the plasma procedure,” Mr. Oyewumi recounted, still grappling with the shock of her sudden loss. “We still have no idea why. No answers. Nothing.”
Ms. Alabede’s death is one of two recent fatalities associated with plasma donations at Grifols centres, leading to national scrutiny of the safety protocols in place at such facilities.
Health Canada Steps In
Health Canada has categorised these incidents as “fatal adverse reactions” and confirmed that they were notified of another death on 30 January, also linked to Grifols. Initially, the federal regulator indicated that there had been four fatalities over the past decade in Canada; this figure was later revised to three deaths since 1 January 2016, all occurring in Manitoba. However, little information has been disclosed about these incidents, including the identities of the deceased.
Mark Johnson, a spokesperson for Health Canada, stated that the agency’s investigations have yet to establish a connection between the deaths and the plasma donations. As investigations continue, Manitoba’s Health Minister Uzoma Asagwara has suggested that the province might consider banning paid plasma donations altogether. “We’re going to do everything we can to make sure that the families have all the answers that they need and deserve,” Asagwara said during a recent press conference.
The Role of Grifols
Grifols, a Spanish pharmaceutical company, operates the only for-profit plasma donation centres in Canada and runs 17 locations across the country. Donors at these centres can give plasma twice a week, receiving compensation ranging from £24 to £80 per donation, depending on various factors. Following the alarming incidents, Grifols announced changes to its policy, requiring donors to wait 48 hours between donations.
Despite these changes, public health advocates have raised concerns regarding the potential dangers of incentivising frequent donations. Critics argue that financial motivations could endanger donor health, while supporters claim that such programmes are essential for maintaining a steady supply of plasma for medical treatments.
Community Concerns
The news of the deaths has unsettled many donors in Winnipeg. Brian Friesen, a regular donor, expressed his apprehension about the safety measures in place. “It’s hard to say it’s about the money, but how could it not be?” he remarked, revealing his own troubling experiences of painful bruising and vein collapse after donations. “I know this is the same place where that young woman died. I know that. But all the people still here are going to tell you the same, if they tell you the truth: We need the cash.”
Similarly, Shawna Wiebe, another donor, noted her uncertainty about continuing to donate after learning about the recent tragedies. “To be honest, because I’ve seen so many bad things here before hearing about these deaths, I’m still not sure if I’ll back out today at the last minute,” she stated as she approached the facility.
The Manitoba Health Coalition has called for greater transparency from both Canadian Blood Services and Grifols regarding their operations and agreements. Noah Schulz, the coalition’s director, stated that the tragic deaths underscored the need to end what he termed a “predatory practice” of paying for plasma donations.
Why it Matters
The unfortunate deaths of Rodiyat Alabede and another donor highlight critical issues surrounding the safety and ethics of paid plasma donation programmes. As investigations proceed, the potential for regulatory reform could reshape the landscape of plasma donation in Canada, balancing the need for medical resources with the imperative to protect the health and safety of donors. Ensuring the well-being of individuals who contribute to this vital aspect of healthcare must remain a priority, fostering a system that prioritises donor safety above financial incentives.
